Second bilateral meeting between European Medicines Agency and Vaccines Europe, European Medicines Agency, Amsterdam, the Netherlands, 27 November 2023

Submitted by Anonymous (not verified) on 5 December 2023 - 11:00

Second bilateral meeting between European Medicines Agency and Vaccines Europe, European Medicines Agency, Amsterdam, the Netherlands, 27 November 2023

Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Leiomyoma, Date of authorisation: 16/07/2021, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 4 December 2023 - 16:41

Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Leiomyoma, Date of authorisation: 16/07/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Yesafili, aflibercept, Macular Edema;Retinal Vein Occlusion;Diabetic Retinopathy;Myopia, Degenerative;Diabetes Complications, Date of authorisation: 15/09/2023, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 4 December 2023 - 16:15

Human medicines European public assessment report (EPAR): Yesafili, aflibercept, Macular Edema;Retinal Vein Occlusion;Diabetic Retinopathy;Myopia, Degenerative;Diabetes Complications, Date of authorisation: 15/09/2023, Revision: 1, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness